--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ZLAB20261218C25
Biotechnology Ⅲ
Zai Lab Limited is a holding company mainly engaged in biopharmaceuticals. The company is committed to addressing unmet medical needs in oncology, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The company has a portfolio of patented drug candidates from the discovery stage to the later stages of clinical programs. These include "Zele", "OPTUNE", "Qingle", "New Zele" and "Weiweijia".
